This Is MS - Daclizumab Shows Promise in Phase II Trial for Relapsing Remitting MS | Unbiased Multiple Sclerosis Research, News, and Community

Modules

· Home
· Content
· Downloads
· Encyclopedia
· FAQ
· Feedback
· Forums
· Journal
· Private Messages
· Recommend Us
· Search
· Site_Map
· Stories Archive
· Submit News
· Surveys
· Top 10
· Topics
· Web Links
· Your Account

Google

These ads help pay for the upkeep of our site. They are automatically served by Google and are not affiliated with This is MS.

Languages

Select Interface Language:

Who's Online

There are currently, 156 guest(s) and 15 member(s) that are online.

You are Anonymous user. You can register for free by clicking here

Next Step

From the creators of This is MS comes Experience Project

EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at Experience Project.

Get started by sharing your Multiple Sclerosis story.

Donations

To remain unbiased, This is MS does not accept corporate sponsorships.

Therefore, we must rely on our users to help support us. Please donate to our upkeep if you have the means. Thank you!

Daclizumab Shows Promise in Phase II Trial for Relapsing Remitting MS

Daclizumab

Just over a year ago, PDL Pharmaceuticals partnered with MS giant Biogen (Avonex, Tysabri) to bring a drug known as daclizumab through trials for MS. Daclizumab is today used for the prevention of kidney transplant rejection, under the marketing name Zenapax (r). The partnership seems to be bearing fruit, as the companies announced that Daclizumab hit its targets in its first Phase II multiple sclerosis trial.

Please click 'read more'

Advertisement

The rest of this story is hosted at our sister site, Experience Project, run by the same team behind This is MS. It is 100% free, and you may read the rest of the article, vote for it if you like it, and submit your own news postings. Experience Project is about sharing stories and connecting people who have multiple life experiences in common-- like parents who have MS. It creates customized support groups of people who really understand each other. We strongly encourage you to join Experience Project (fast, free and anonymous), share your MS story, and let us know if you you like what you see!

Click to Read: Minimal Changes in Cognitive Function of Relapsing-Remitting MS'ers in a 10-year clinical trial. (link opens in new window)

Login

Don't have an account yet? You can create one. As a registered user you have some advantages like theme manager, comments configuration and post comments with your name.

Related Links

· More about Daclizumab
· News by Administrator

Most read story about Daclizumab:
Daclizumab Method of Action Surprises Researchers

Article Rating

Average Score: 0
Votes: 0

Options

Printer Friendly

Printer Friendly

Re: Daclizumab Shows Promise in Phase II Trial for Relapsing Remitting MS (Score: 1)
by Shayk on Monday, March 19 @ 21:36:26 EDT
(User Info | Send a Message)

I can't seem to locate a link to the rest of the story.

Re: Daclizumab Shows Promise in Phase II Trial for Relapsing Remitting MS (Score: 1)
by Grumpster (dgwhitman@sbcglobal.net) on Wednesday, March 21 @ 17:13:28 EDT
(User Info | Send a Message)

Where is the article - the link on the page is to the brain function article and I already know mine is poor :) Admin Arron, please fix.

Re: Daclizumab Shows Promise in Phase II Trial for Relapsing Remitting MS (Score: 1)
by Arron on Saturday, March 24 @ 23:33:31 EDT
(User Info | Send a Message)

The link has been fixed-- thanks for alerting us!

Personal Stories about millions of life experience--including multiple sclerosis support, lupus support, depression support . Built by the This is MS team.

Anonymous Confessions | Dream Dictionary
Site Map

This site does not offer medical advice. All treatment decisions should always be made with the full consent of your physician.

Visit our sister site dedicated to Inflammatory Bowel Disease: This is IBD

All logos and trademarks in this site are property of their respective owners. The comments are property of their posters, quoted articles are © referenced source, all the rest © 2002 by thisisMS.com.
PHP-Nuke Copyright © 2005 by Francisco Burzi. This is free software, and you may redistribute it under the GPL. PHP-Nuke comes with absolutely no warranty, for details, see the license.
Page Generation: 0.09 Seconds